Viewing Study NCT00562250


Ignite Creation Date: 2025-12-24 @ 5:04 PM
Ignite Modification Date: 2026-03-08 @ 11:44 PM
Study NCT ID: NCT00562250
Status: COMPLETED
Last Update Posted: 2016-10-17
First Post: 2007-11-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Pharmacokinetic Drug Interaction Study With Dapagliflozin and Glimepiride in Healthy Subjects
Sponsor: AstraZeneca
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: MB102-016
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View